Infectious Diseases Unit, St. Vincent's Hospital, 1 Lochner St., West Hobart, Melbourne, Victoria 7000, Australia.
Antimicrob Agents Chemother. 2010 Sep;54(9):3949-52. doi: 10.1128/AAC.00212-10. Epub 2010 Jun 14.
Thirty-six patients were treated with pristinamycin for 46 different microbiological isolates between April 2007 and July 2009. Pathogens included 9 methicillin-resistant Staphylococcus aureus isolates, 13 methicillin-resistant coagulase negative staphylococci, and 9 vancomycin-resistant enterococci. Sites of infections included 12 osteomyelitis cases, 10 prosthetic joints, 4 other prostheses, and 1 epidural abscess. Five patients ceased treatment due to side effects. Ten patients were cured of their infections, and 21 patients had infections successfully suppressed.
36 例患者在 2007 年 4 月至 2009 年 7 月期间接受了普司他汀治疗 46 种不同的微生物分离物。病原体包括 9 株耐甲氧西林金黄色葡萄球菌分离株、13 株耐甲氧西林凝固酶阴性葡萄球菌和 9 株万古霉素耐药肠球菌。感染部位包括 12 例骨髓炎病例、10 例人工关节、4 例其他假体和 1 例硬膜外脓肿。5 例患者因副作用停止治疗。10 例患者感染治愈，21 例患者感染得到有效抑制。
